Presentation of VivaSant
- 3 -
A Family Group Focused on Long-Term Growth and International Development
BTG Industries & Sant is a French family office fully owned by the Le Lous family
The business traces its origins in 1949 when Jean Le Lous becomes the Chairman of Laboratoires Fournier Sarl, that will turn in less than 50 years the 4th independent pharmaceutical player in France
Soon enough in 1958, operations of the Group were divided in two core businesses: Fournier Pharma, the ethical division Laboratoires Urgo, that will become leader in wound treatment
In 2006, VivaSant divested Fournier Pharma to Solvay Group and re-
centered its activities on 2 poles: Advanced Wound Management Self-Medication
H. Le Lous Chairman
C. Arend CFO
P. Moustial COO
- 4 -
The DNA of VivaSant VivaSant has a corporate culture underpinned by its DNA, at the center is Innovation
Entrepreneurship
Adaptability
Excellence
Consumer focus
Innovation
We encourage entrepreneurs initiatives and audacity. We strongly believe that to succeed, you should test, try and think out of the box
Consumer is the cornerstone of our business. We work
continuously with one objective: to bring the most
suitable answers to his needs and ailments
Offering best in class products, looking for a
number 1 position
To succeed worldwide, to maintain a leading position on our markets, we have to be flexible and to keep our eyes and ears open
- 5 -
VivaSant Group structure Four business units generating 520M worldwide
2013 sales : 517 M
2 200 people
2011 : 109M 2011 : 118M 2011 : 31M
350 people 180 people
Pharmacies Retail, Mass Market
Hospital & Community Natural Health & herbal medicine
Speciality Care Consumer Healthcare
194M 34M 126M
163M
1650 people
- 6 -
Urgo Medical N3 on the European Advanced Wound Care Market
Urgo medical provides gold standard dressings for the treatment of serious incapacitating solutions : Burns Leg ulcers Epidermolysis bullosa Diabetic foot ulcers Pressure sores
Starting this activity in 2000, Urgo Medical revolutionised
the wound healing market by inventing UrgoTul , a dressing based on the Technology Lipido Colloid (TLC) for the management of acute and chronic wounds : Healing in a moist environment Promoting fibroblast proliferation Easy to remove with pain-free dressing changes Protecting and improving the surrounding skin Now most prescribed product on the European Advanced
Wound Care market
- 7 -
A the heart of Urgo Medical success: the TLC Technology A unique combination of hydrocolloid and lipid particles on a non-occlusive polyester mesh
- 8 -
Urgo Medic was then developed as the booster version of TLC for diabetic, arteritic and venous insufficient patients: NOSF component designed to neutralize excess proteases,
therefore rebalancing wound equilibrium and accelerating wound healing
Urgo Start benefited from the first-ever comparative randomised, controlled, double-blind study, which showed that UrgoStart speeds up wound healing X2
In 2011, we launched UrgoClean , an ultra-absorbent dressing with hydro-desloughing fibres for sloughy exuding wounds: Clean the wound, absorbs exudates and traps slough
Traps bacteria
Urgo Medical N3 on the European Advanced Wound Care Market
- 9 -
Urgo Medical Strategy: to have one dressing for each requirement
Thanks to this strategy and commitment, Urgo Medical became in less than 10 years N1 in France and N 3 on the European Advanced Wound Care market
- 10 -
Humex - Humer The Specialist of Ear Nose and Throat pathologies
2 leading brands: Humex and Humer
Best in class products for treatment of upper respiratory track disorders
OTC and Medical Devices status
N1 in France on the allergy market
Strong presence in Romania, Ukraine, Baltic States and North Africa
Allergies, hay fever,
allergic rhinitis, allergic
conjunctivitis
Complete range for cold
treatment, cough, sore
throats and flu-like symptom
Cough & Cold
Allergies
The very best of the sea water
for ear/nose hygiene and
nasal decongestion
Sea Water Spray
85% brand awareness
Distribution in pharmacies
- 11 -
Urgo & Mercurochrome N1 in France in first aid and wound treatment
Mercurochrome: 98% brand awareness in France. N1 in modern trade and mass market
Urgo: 85% brand awareness in France. N1 in pharmacies
Through these 2 brands, VivaSant built a solid reputation in wound care, revolutionising the traditional dressings market with innovative forms, such as its Filmogel (liquid dressing), and expanding its treatment ranges to include mouth wounds, pain relief and support
Voted most innovative OTC pharmaceutical company by pharmacists 3 years in succession
Strong presence in Portugal, Spain, Baltic States and Vietnam
Liquid plasters and dedicated solutions for
skin cracks, cold sores, damaged
nails, scars and mouth ulcers
Mouthcare, Hand & Foot
First-aid:
Plasters & Antiseptics
Leading brand for
wound care
- 12 -
Juvamine and Alvityl Prevention and Nutrition expertise
pioneer of dietary supplements products in mass market (multivitamins, Omega 3, nutrition, herbal products, etc.).
Leading brand in French supermarkets with more than 60% market shares
complex of multivitamins prescribed and recommended by paediatricians
Several other brands for well-being: OM3, Immunostim
Balance, energy, Vitamins & Minerals, Slimming and
Herbal therapy
93% brand awareness
Health Immune defences Balance & energy
Prevention & Nutrition Health
Food supplements
- 13 -
Super Diet Specialist in natural and organic products for self-prescription
Dietary supplement with natural and organic active principles Major brands in phytotherapy, natural medication and self-medication High-end products (clinical studies, highly concentrated products, easy to use) Products sold in pharmacies, organic and dietetic shops
Distribution in specialised stores
- 14 -
Our leading positions in France in short
- 15 -
The success stories of our brands around the world
Vietnam
Czech Republic
Algeria Belgium Vietnam Ukraine Baltic States Romania Algeria
N1 on traditional plasters (over 2M sales)
N1 on blister plasters with 48,5% MS
More than 100Ku of Urgo Mouth Ulcer sold in 2012. 98% brand awareness among pharmacists 93% brand awareness among pharmacists N2 with over 200ksales (launch in 2010) More than 1Mn units sold in 2012 with 48% MS N1 on the sea water market N2 on the sea water and cough & cold market N1 with 36,2% MS 41% brand awareness amoung consumers 99% brand awareness among GPs
- 21 -
VivaSant in summary
France is a land of excellence for healthcare. A network of researchers in all our fields of interest, highly efficient healthcare institutions and a firmly established industrial tradition form the fundations on which VivaSant has built its success
Every man and woman working at VivaSant is firmly committed to safety and efficacy of our product lines. Our shared determination is to have recognized solutions to each ailment of the day to day life and to be in each country where we enter, the partner for health of every patient